ERBB2 (also known as HER2) is a commonly amplified and overexpressed proto-oncogene in a subset of breast cancer (Slamon et al., 1987; Slamon et al., 1989; Cancer Genome Atlas Network, 2012). This evidence concerns the gene ERBB2 and breast cancer.